Physician

Adam Mika Kruszewski, MD

According to 2025 Medicare claims, Adam Kruszewski, MD (NPI: 1154850212) practices neurology in the Philadelphia, PA market, with the plurality of this provider's patient population coming from Philadelphia, PA. This provider's primary affiliated billing organization is UNIVERSITY OF PENN-MEDICAL GROUP (NPI: 1164810271; TIN: 232743545) and primary practice location at 19104-5127.

Kruszewski's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 229 traditional Medicare patients, billed 814 HCPCS/CPT codes, and received $50,556 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 124 prescription claims across 43 beneficiaries totaling $15,962 in drug costs, led by Gabapentin (Gabapentin). Open Payments data shows 1 records totaling $122. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have fallen sharply in recent years, from $7,955 to $15,962. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$25K$51K2022 Medicare payment: $3,277 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $44,942 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $50,556 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
20223550$3,277
2023249561$44,942
2024229814$50,556

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$15K$31K2017 Drug cost: $7,955 (USD; Tot_Drug_Cst)2018 Drug cost: $5,843 (USD; Tot_Drug_Cst)2019 Drug cost: $22,760 (USD; Tot_Drug_Cst)2020 Drug cost: $29,829 (USD; Tot_Drug_Cst)2021 Drug cost: $30,889 (USD; Tot_Drug_Cst)2022 Drug cost: $4,214 (USD; Tot_Drug_Cst)2023 Drug cost: $6,411 (USD; Tot_Drug_Cst)2024 Drug cost: $15,962 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
20171844$7,955
20182986$5,843
201925123$22,760
202024134$29,829
202121109$30,889
20222970$4,214
202346165$6,411
202443124$15,962

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99205New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more9595$140
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more149226$110
92060Exam to measure eye deviation and range of motion9399$29
92083Exam of visual field with extended testing7099$20
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's100137$13

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
GabapentinGabapentin15577$168
PrednisonePrednisone20927$114

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$122Alexion Pharmaceuticals, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Adam Mika Kruszewski, MD?

Tedicare shows public-source Medicare data for Adam Mika Kruszewski, MD (NPI 1154850212), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam Mika Kruszewski, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Adam Mika Kruszewski, MD?

Adam Mika Kruszewski, MD is linked to UNIVERSITY OF PENN-MEDICAL GROUP (billing NPI 1164810271) in the available physician profile data.

Does Adam Mika Kruszewski, MD have Open Payments data?

Adam Mika Kruszewski, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.